Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Ulf Gerdtham. Foto.

Ulf Gerdtham

Professor

Ulf Gerdtham. Foto.

Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study

Författare

  • Fredrik Liedberg
  • Ulf Gerdtham
  • Katarina Gralén
  • Sigurdur Gudjonsson
  • Staffan Jahnson
  • Irene Johansson
  • Oskar Hagberg
  • Staffan Larsson
  • Anna Karin Lind
  • Annika Löfgren
  • Jenny Wanegård
  • Hanna Åberg
  • Mef Nilbert

Summary, in English

Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder cancer. Median time from patient-reported haematuria to diagnosis was 29 (interquartile range (IQR) 14−104) days and 50 (IQR 27−165) days in the intervention and the control group, respectively (P=0.03). The median health-care costs were lower in the intervention group (655 (IQR 655−655) EUR) than in the control group (767 (IQR 490−1096) EUR) (P=0.002).Conclusions:Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.British Journal of Cancer advance online publication, 25 August 2016; doi:10.1038/bjc.2016.265 www.bjcancer.com.

Avdelning/ar

  • EpiHealth: Epidemiology for Health
  • Urologi - blåscancer, Malmö
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
  • Bröstcancer-genetik
  • Hälsoekonomi
  • Urologi
  • Medicinsk onkologi

Publiceringsår

2016-08-25

Språk

Engelska

Sidor

770-775

Publikation/Tidskrift/Serie

British Journal of Cancer

Volym

115

Dokumenttyp

Artikel i tidskrift

Förlag

Nature Publishing Group

Ämne

  • Urology and Nephrology
  • Cancer and Oncology

Nyckelord

  • urologic care
  • macroscopic haematuria

Status

Published

Projekt

  • Precision Medicine in Hereditary Cancer and Sarcoma; targeted surveillance, immunotherapy and individualized follow-up
  • Precision Medicine in Hereditary Cancer and Sarcoma; targeted surveillance, immunotherapy and individualized follow-up

Forskningsgrupp

  • Urology - urothelial cancer, Malmö
  • Health Economics
  • Urology

ISBN/ISSN/Övrigt

  • ISSN: 0007-0920